|
| |
| | | 61532 | | 14.06.2012 | | GlaxoSmithKline AG | | | | | | | | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Benlysta 120 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Belimumabum 120 mg) | L04AG04 | | | 02 | Benlysta 400 mg | Pulver zur Herstellung einer Infusionslösung | Lyophilisate (Belimumabum 400 mg) | L04AG04 | |
|
|
|
